2月12日,来自前线的武汉大学移植中心副主任王彦峰教授在直播中为我们介绍了关于武汉移植患者感染新冠肺炎的诊治情况,并讲解了二例肾移植患者感染新冠肺炎的案例。
更多详情请扫描下方二维码,观看回放视频
News in Transplantation
2月12日,来自前线的武汉大学移植中心副主任王彦峰教授在直播中为我们介绍了关于武汉移植患者感染新冠肺炎的诊治情况,并讲解了二例肾移植患者感染新冠肺炎的案例。
更多详情请扫描下方二维码,观看回放视频
The company was founded in 2004 with a registered capital of RMB 70.4 million and 194 employees worldwide, including 46 R&D staff members. The company focuses on organ transplantation as a provider of medical products and professional services for the global market around the entire transplant process. Focusing on the needs of organ transplantation surgeons and patients, we provides medical devices and professional services related to organ transplantation, mainly involving products for the preservation, transportation, evaluation and repair of transplanted organs and in vitro diagnostic reagents for individualized and precise diagnosis of transplant patients, which are exported to about 46 countries and regions worldwide.